The Cancer Epigenetics Society is the official society for cancer epigenetics research. Its most senior members may be involved in several functions associated with its leadership, scientific direction, and journals’ editorial boards.

Presidency

I.M. Bennani-Baiti
President & CEO
Medical Genetics Council, Royal Society of Medicine
Editor, Cancer Control & Cancer Informatics
Cancer Epigenetics Society, Vienna, Austria
K.D. Robertson
Vice-President
Professor of Molecular Pharmacology
and Experimental Therapeutics
Mayo Clinic, Rochester, USA
R.A. Urrutia
Chief Science Officer
Director, Human and Molecular Genetics Center
Wisconsin Medical College
Milwaukee, WI, USA

Society Officers

C. David Allis†
Member, National Academy of Sciences, USA
2015 Breakthrough Prize laureate
2018 Lasker Award laureate
Joy and Jack Fishman Professor
Rockefeller University, New York, NY, USA
Cheryl Arrowsmith
Chief, Structural Genomics Consortium
Board of Directors, Acad. Drug Discov. Consortium
Senior Scientist, Princess Margaret Cancer Centre
Professor of Medical Biophysics,
University of Toronto, Toronto, Canada
Sir Shankar Balasubramanian
 Fellow, Royal Society & Academy Med. Sciences
Inventor of Solexa NGS sequencing
Founder of Solexa & Cambridge Epigenetix
Herchel Smith Professor of Medicinal Chemistry
University of Cambridge, Cambridge, UK
Stephen B. Baylin
Member, National Academy of Sciences, USA
Co-founder, SU2C Epigenetics Dream Team
Chief, Cancer Biology Division & Assoc. Director,
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University, Baltimore, MD, USA
Stephan Beck
Fellow, Academy of Medical Sciences, UK
Former Head, Human genome sequencing project
Co-founder, Human Epigenome Project
Member of faculty of 1000 (f1000) & Professor,
Univ College London Cancer Inst, London, UK
Susan J. Clark
Fellow, Australian Academy of Science, & Head
Genomics & Epigenetics Div., Garvan Inst. Med. Res.
Co-founder, Intl Human Epigenome Consortium
Head, Cancer Res. Div., Kinghorn Cancer Centre
Professor, University NSW, Sydney, Australia
 
Sharon Y.R. Dent
Director, Virginia Harris Cockrell Cancer Res. Center
Director, Center for Cancer Epigenetics
Professor and J. Ralph Meadows Chair
Department of Epigenetics & Molecular Carcinogenesis
Univ Tex. MD Anderson Cancer Ctr., Houston, TX, USA

James Herman
Co-Director, Medical Oncology Fellowship Program
Co-Director, Lung Cancer Program
Head, NCI-UPCI Lung Cancer SPORE
Professor of Medicine, Division of Hematology/Oncology
University Pittsburgh, Pittsburgh, PA, USA

Peter Jones
Member, National Academy of Sciences, USA
Former President, AACR
Co-founder, SU2C Epigenetics Dream Team
Director, Center for Epigenetics, and CSO,
Van Andel Research Institute, Grand Rapids, MI, USA

Jonathan D. Licht
Marshall E. Rinker Sr. Foundation Chair & Director
University of Florida Health Cancer Center
Co-leader, Chicago Physical Sciences Oncology Center
PI, Leukemia & Lymphoma Society Specialized Center
PI, Multiple Myeloma Research Foundation program

Owen A. O’Connor
Director, Center for Lymphoid Malignancies,
Herbert Irving Comprehensive Cancer Center
Director, Therasis, Inc.
Professor of Medicine & Experimental Therapeutics
Columbia University, New York, NY, USA
Christopher J. Schofield
Fellow, Royal Society
Advisory Research Panel Member,
Biotech. & Biol. Sciences Research Council (BBSRC)
Head, Department of Organic Chemistry
University of Oxford, Oxford, UK
Ayalew Tefferi
Faculty, Annual Hematology/Oncology Board
Harvard & George Washington Universities
Professor of Internal Medicine,
Professor of Hematology,
Mayo Clinic, Rochester, MN, USA
Jerry Workman
Member, American Academy of Arts and Sciences
Former Investigator, Howard Hughes Medic. Inst. (HHMI)
Scientific Board Counselor, Nat. Cancer Institute (NCI)
Investigator, Stowers Institute for Medical Research
Kansas City, MO, USA

Senior Members

Paola B. Arimondo
Coordinator, Epichembio WG1
Director, CNRS-USR 3388,
Epigenetic Targeting of Cancer
Toulouse, France
Andrew Bannister
Senior Research Associate
Wellcome Trust CRUK Gurdon Institute
University of Cambridge
Cambridge, UK
Thomas Carell
Member, National Academy Leopoldina
Professor of Chemistry,
Ludwig Maximillians University
Munich, Germany
Hetty Carraway
Program Director,
Hematology/Oncology
Taussig Cancer Inst., Cleveland Clinic
Cleveland, OH, USA
Giacomo Cavalli
EpigeneSys Network of Excellence 
Head, Chromatin & Cell Biology Lab
Institute for Human Genetics,
Montpellier, France
Jeffrey Craig
Assoc. Prof., Genetic Epidemiology
Murdoch Children’s Research Institute
Assoc. Professor, Dept. Pediatrics
Univ. Melbourne, Melbourne, Australia
Luciano Di Croce

Member, EMBO
Head, Epigenetic Events in Cancer
Centre for Genomic Regulation
Barcelona, Spain

Alexander Dobrovic
Head, Transl. Genomics & Epigenomics
Olivia Newton-John Cancer Res. Inst.
Associate Professor, Dept. Pathology
Univ. Melbourne, Melbourne, Australia
Arasu Ganesan
Member, Royal Society of Chemistry
Co-founder, Karus Therapeutics
Professor, Chemical Biology
University of East Anglia, Norwich, UK
Lucy A. Godley
Prof., Department of Medicine,
Section of Hematology/Oncology
University of Chicago,
Chicago, IL, USA
Ajay Goel
Drirector, Center for Epigenetics,
Cancer Prevention & Cancer Genomics
Baylor University Medical Center
Dallas, TX, USA
Nada Javado
Fellow, Royal Society of Canada
Prof., Pediatrics & Human Genetics 
McGill University
Montreal, Canada
Ricky Johnstone
Associate Director, Lab. Research
Head, Gene Regulation Laboratory
Peter MacCallum Cancer Centre
Melbourne, Australia
Cigall Kadoch
Asst. Prof., Dana-Farber Cancer Institute
& Harvard Medical School
Member, Broad Institute, MIT / Harvard
Boston, MA, USA
Charles Keller
Scientific Director,
Children’s Cancer Therapy
Development Institute
Beaverton, USA
Jan Korbel
Head, Genome Biology Unit & Leader
Molecular Medicine Partnership Unit
European Molecular Biology Laboratory
(EMBL), Heidelberg, Germany
Tatiana Kutateladze
Professor of Pharmacology,
Structural Biology and Biochemistry
University of Colorado Cancer Center
Aurora, CO, USA
Christoph Plass
Division Head
Epigenomics & Cancer Risk Factors
German Cancer Research Center
(DKFZ), Heidelberg, Germany
Ana Pombo
Head, Epigenetic Regulation
and Chromatin Architecture
Professor, Max Delbrück Center for
Molecular Medicine, Berlin, Germany
Aldo Roccaro
Medical Director,
Clinical Research and 
Coordination, and Design
ASST Spedali Civili, Brescia, Italy
Mukesh Verma
Chief, Epidemiology & Genomics
Research Program, Div. Cancer Control
and Population Sciences, NCI / NIH
Rockville, MD, USA